Committee

Tomáš Adam, Institute of Molecular and Translational Medicine, Palacky University in Olomouc, Czechia

Karl Burgess, Glasgow Polyomics Metabolomics Facility, Translational Cancer Research Centre, University of Glasgow, United Kingdom

Peter Filzmoser, Institute of Statistics and Mathematical Methods in Economics, Vienna University of Technology, Austria

David Friedecký, Institute of Molecular and Translational Medicine, Palacky University in Olomouc, Czechia

Karel Hron, Faculty of Science, Palacky University in Olomouc, Czechia

Jennifer Kirwan, Berlin Institute of Health / Max Delbrück Center for Molecular Medicine, Germany

Reza Salek, WHO, International Agency for Research on Cancer, Lyon, France

img_8488-org-comm